Fibrin Fibrinogen Degradation Products

"Fibrin Fibrinogen Degradation Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.

Descriptor ID	D005338
MeSH Number(s)	D12.776.124.270.300 D12.776.811.300.290
Concept/Terms	Fibrin Fibrinogen Degradation Products Fibrin Fibrinogen Degradation Products Fibrin Degradation Products Degradation Products, Fibrin Fibrin Fibrinogen Split Products Antithrombin VI

Below are MeSH descriptors whose meaning is more general than "Fibrin Fibrinogen Degradation Products".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Fibrin [D12.776.124.270]
Fibrin Fibrinogen Degradation Products [D12.776.124.270.300]
Protein Precursors [D12.776.811]
Fibrinogen [D12.776.811.300]
Fibrin Fibrinogen Degradation Products [D12.776.811.300.290]

Below are MeSH descriptors whose meaning is related to "Fibrin Fibrinogen Degradation Products".

Below are MeSH descriptors whose meaning is more specific than "Fibrin Fibrinogen Degradation Products".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fibrin Fibrinogen Degradation Products" by people in this website by year, and whether "Fibrin Fibrinogen Degradation Products" was a major or minor topic of these publications.

Bar chart showing 32 publications over 18 distinct years, with a maximum of 5 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	1	1
2005	0	1	1
2006	1	0	1
2007	1	3	4
2008	0	1	1
2009	1	2	3
2010	1	0	1
2011	0	1	1
2012	0	2	2
2013	0	1	1
2014	0	1	1
2015	0	1	1
2016	1	0	1
2017	1	0	1
2018	2	2	4
2019	0	1	1
2020	0	2	2
2021	1	4	5

Below are the most recent publications written about "Fibrin Fibrinogen Degradation Products" by people in Profiles.

Elberts SJ, Bateman R, Koutsoubis A, London KS, White JL, Fields JM. The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. 2021 10; 28(10):1142-1149.

View in: PubMed
Zmistowski B, Chang M, Shahi A, Nicholson T, Abboud J, Lazarus M, Williams G, Parvizi J, Namdari S. Is D-dimer a Reliable Serum Marker for Shoulder Periprosthetic Joint Infection? Clin Orthop Relat Res. 2021 07 01; 479(7):1447-1454.

View in: PubMed
Azboy I, ?atal B, Basarir K, Mutlu M, Bilgen ?F, Parvizi J. The Natural Course of Serum D-Dimer, C-Reactive Protein, and Erythrocyte Sedimentation Rate Levels After Uneventful Primary Total Joint Arthroplasty. J Arthroplasty. 2021 09; 36(9):3118-3122.

View in: PubMed
Barnes DH, Lo KB, Bhargav R, Gul F, DeJoy R, Peterson E, Salacup G, Pelayo J, Albano J, Azmaiparashvili Z, Rangaswami J, Carpio AM, Patarroyo-Aponte G. Predictors of venous thromboembolism in patients with COVID-19 in an underserved urban population: A single tertiary center experience. Clin Respir J. 2021 Aug; 15(8):885-891.

View in: PubMed
Reagh JJ, Zheng H, Stolz U, Parry BA, Chang AM, House SL, Giordano NJ, Cohen J, Singer AJ, Francis S, Prochaska JH, Zeserson E, Wild PS, Limkakeng AT, Walters EL, LoVecchio F, Theodoro D, Hollander JE, Kabrhel C, Fermann GJ. Sex-related differences in D-dimer levels for venous thromboembolism screening. Acad Emerg Med. 2021 08; 28(8):873-881.

View in: PubMed
Hammer MM, Hunsaker AR, Gooptu M, Hatabu H. Frequency of Pulmonary Embolism in Patients With COVID-19. JACC Cardiovasc Imaging. 2020 Nov; 13(11):2478-2479.

View in: PubMed
Hiedra R, Lo KB, Elbashabsheh M, Gul F, Wright RM, Albano J, Azmaiparashvili Z, Patarroyo Aponte G. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther. 2020 Dec; 18(12):1259-1261.

View in: PubMed
Shohat N, Tan TL, Della Valle CJ, Calkins TE, George J, Higuera C, Parvizi J. Development and Validation of an Evidence-Based Algorithm for Diagnosing Periprosthetic Joint Infection. J Arthroplasty. 2019 Nov; 34(11):2730-2736.e1.

View in: PubMed
Parks C, Bounds R, Davis B, Caplan R, Laughery T, Zeserson E. Investigation of age-adjusted D-dimer using an uncommon assay. Am J Emerg Med. 2019 07; 37(7):1285-1288.

View in: PubMed
Pahys JM. Intraoperative Coagulopathy 101: Are Antifibrinolytics the Answer and How Do They Work?: Commentary on an article by Ryan P. Pong, MD, et al.: "Effect of Tranexamic Acid on Blood Loss, D-Dimer, and Fibrinogen Kinetics in Adult Spinal Deformity Surgery". J Bone Joint Surg Am. 2018 05 02; 100(9):e63.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement